Table 2:

Number of people who ever had the study outcome observed during the approximate 10-year follow-up period*

OutcomeTotal
n = 696		General population
n = 580		First Nations
n = 116
Outpatient gastroenterologist visit57948594
Colonoscopy610504106
Prescription claim for IBD61051892
Prescription claim of a biologic16014515
Prescription claim of an IM26423232
Prescription claim of a 5-ASA56047288
IBD-specific hospitalization34928663
IBD-related hospitalization38030674
Surgery for IBD23019436

  • Note: 5-ASA = 5-aminosalicylic acid, IBD = inflammatory bowel disease, IM = immune modulator.

  • ↵* No recurrent events were included.